Virtus ETF Advisers’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,979
| Closed | -$71K | – | 617 |
|
|
2024
Q4 | $71K | Sell |
3,979
-7,411
| -65% | -$132K | 0.03% | 364 |
|
|
2024
Q3 | $249K | Buy |
11,390
+200
| +2% | +$4.38K | 0.12% | 241 |
|
|
2024
Q2 | $87.3K | Sell |
11,190
-21,625
| -66% | -$169K | 0.04% | 372 |
|
|
2024
Q1 | $136K | Sell |
32,815
-2,254
| -6% | -$9.33K | 0.07% | 338 |
|
|
2023
Q4 | $91.5K | Sell |
35,069
-15,645
| -31% | -$40.8K | 0.06% | 401 |
|
|
2023
Q3 | $94.8K | Sell |
50,714
-5,049
| -9% | -$9.44K | 0.06% | 340 |
|
|
2023
Q2 | $140K | Sell |
55,763
-53,998
| -49% | -$136K | 0.08% | 323 |
|
|
2023
Q1 | $192K | Buy |
109,761
+66,926
| +156% | +$117K | 0.11% | 310 |
|
|
2022
Q4 | $182K | Buy |
+42,835
| New | +$182K | 0.1% | 321 |
|